Testing effectiveness (Phase 2)Study completedNCT02048371
What this trial is testing
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
Who this might be right for
LiposarcomaOsteogenic SarcomaEwing/Ewing-like Sarcoma+2 more
Sarcoma Alliance for Research through Collaboration 131